tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

New Ray Medicine Schedules Board Meeting for Interim Results

Story Highlights
New Ray Medicine Schedules Board Meeting for Interim Results

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

New Ray Medicine International Holding Ltd. ( (HK:6108) ) just unveiled an update.

New Ray Medicine International Holding Ltd. has announced a board meeting scheduled for August 27, 2025, to review and approve the unaudited interim results for the first half of 2025. The meeting will also consider the potential payment of a dividend, which could impact shareholder returns and market perception.

More about New Ray Medicine International Holding Ltd.

New Ray Medicine International Holding Ltd. is a company incorporated in Bermuda, operating within the pharmaceutical industry. It focuses on the development and distribution of medical products and services.

Average Trading Volume: 369,513

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$69.38M

For a thorough assessment of 6108 stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1